Citation Tools
PDFRegular and young investigator award abstracts
Clinical trials completed
289 PGV-001: a phase 1 trial of a personalized neoantigen peptide vaccine for the treatment of malignancies in the adjuvant setting
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 289 PGV-001: a phase 1 trial of a personalized neoantigen peptide vaccine for the treatment of malignancies in the adjuvant setting